Papers on hyperkalemia
152 papers58 new in 30 days
Wednesday, November 18
Tuesday, November 17
Frontiers in Endocrinology
Influence of Sequential Timing between Dapagliflozin and Finerenone on Short-term Renal Outcomes in Diabetic Kidney Disease: a real-world observational study from China
Accepted, not yet published: cohort study of 201 peopleFinerenone
Monday, November 16
JRSM Cardiovascular Disease
The role of aldosterone synthase inhibitors in hypertension: A systematic review and meta-analysis
Meta-analysis of randomized trialsAldosterone synthase inhibitors
Saturday, November 14
Wednesday, November 11
European Journal of Case Reports in Internal Medicine
Iatrogenic Hypercalcemia in A Patient with Type 2 Diabetes and Chronic Kidney Disease
Case reportChronic kidney disease
Tuesday, November 10
Annals of Medicine and Surgery
Comparative efficacy and safety of lorundrostat and baxdrostat in uncontrolled hypertension: a placebo-anchored indirect treatment comparison using the Bucher method

Meta-analysis of randomized trialsLorundrostat
Monday, November 9
The British Journal of Nutrition
Dietary potassium intake from different food sources and mortality in maintenance haemodialysis patients: a multicentre prospective cohort study
Cohort study in peoplePopulations
AHA Scientific Sessions 2026 Abstract
Efficacy and Safety of Baxdrostat for Hypertension: A Systematic Review and Meta-Analysis of Three Phase 2/3 Randomized Controlled Trials
Meta-analysis of randomized trialsBaxdrostat
AHA Scientific Sessions 2026 Abstract
Baxdrostat in Resistant and Uncontrolled Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis of randomized trialsBaxdrostat
AHA Scientific Sessions 2026 Abstract
Angiotensinogen-Targeting RNA Interference with Zilebesiran for Hypertension: A Systematic Review and Meta-Analysis of Randomized Trials
Meta-analysis of randomized trialsZilebesiran
AHA Scientific Sessions 2026 Abstract
Efficacy and Safety of Aldosterone Synthase Inhibitors in Controlling Treatment-Resistant Hypertension: A GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis of randomized trialsAldosterone synthase inhibitors
AHA Scientific Sessions 2026 Abstract
Baxdrostat Efficacy and Safety According to Baseline Clinical Characteristics: Subgroup Analyses of the BaxHTN Trial
Randomized trial in peopleBaxdrostat
Saturday, November 7
AHA Scientific Sessions 2026 Abstract
Hepatic Angiotensinogen-Lowering RNA Therapeutics for Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis of randomized trialsHypertension
AHA Scientific Sessions 2026 Abstract
Cardiovascular and Renal Outcomes of Renin-Angiotensin-Aldosterone System Inhibitor Continuation versus Discontinuation in Patients with Heart Failure and Chronic Kidney Disease Stage 3a: A Propensity Matched Real World Analysis
Cohort study of 4,682 peopleHeart failure
AHA Scientific Sessions 2026 Abstract
Combination of Finerenone with Empagliflozin According to Frailty Status Among Participants with Type 2 Diabetes and CKD in the CONFIDENCE Trial
Trial in 796 peopleFinerenone + empagliflozin
AHA Scientific Sessions 2026 Abstract
Combination of Finerenone with Empagliflozin Across the Spectrum of Risk of Kidney Failure: The CONFIDENCE Trial
Randomized trial in 780 peopleFinerenone + empagliflozin
AHA Scientific Sessions 2026 Abstract
Clinical Outcomes of Novel Aldosterone Synthase Inhibitors (Lorundrostat and Baxdrostat) in Low and High Dose in Uncontrolled Hypertension: A Systematic Review and Meta-Analysis of RCTs
Meta-analysis of randomized trialsLorundrostat
AHA Scientific Sessions 2026 Abstract
Blood Pressure-Lowering Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension: A Systematic Review, Meta-Analysis, and Dose-Response Analysis with Trial Sequential Analysis
Meta-analysis of randomized trialsBaxdrostat
AHA Scientific Sessions 2026 Abstract
Racial and Ethnic Differences in the Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio: The CONFIDENCE Trial
Trial in 789 peopleFinerenone + empagliflozin
AHA Scientific Sessions 2026 Abstract
Comparative Efficacy and Safety of Aldosterone Synthase Inhibitors versus Mineralocorticoid Receptor Antagonists for Resistant Hypertension: A Systematic Review and Network Meta-Analysis
Meta-analysis of randomized trialsResistant hypertension
AHA Scientific Sessions 2026 Abstract
Time in Normal-High Potassium Range and Cardiovascular Outcomes in Cardio-Kidney-Metabolic Syndrome: A FINE-HEART Analysis
Cohort study of 18,991 peopleCardio-kidney-metabolic syndrome
AHA Scientific Sessions 2026 Abstract
Finerenone Plus SGLT2 Inhibitors versus SGLT2 Inhibitor Monotherapy for Cardiorenal Outcomes: An Updated Meta-Analysis
Meta-analysis of studies in peopleFinerenone
AHA Scientific Sessions 2026 Abstract
Comparative Outcomes of Baxdrostat 0.5mg, 1mg, and 2mg in Hypertension: A Systematic Review and Network Meta-Analysis
Meta-analysis of randomized trialsBaxdrostat
AHA Scientific Sessions 2026 Abstract
Aldosterone Synthase Inhibitors in Adequate Blood Pressure Control in Uncontrolled/Resistant Hypertension: A Meta-Analysis of Randomized Controlled Trials
Meta-analysis of randomized trialsAldosterone synthase inhibitors
AHA Scientific Sessions 2026 Abstract
Baxdrostat for Resistant Hypertension: A Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis of randomized trialsBaxdrostat
AHA Scientific Sessions 2026 Abstract
Nocturnal Blood Pressure Reduction with Baxdrostat: A Targeted Literature Review and Meta-Analysis
Meta-analysis of randomized trialsBaxdrostat
AHA Scientific Sessions 2026 Abstract
Safety, Efficacy, and Renal Effects of Baxdrostat in Controlled versus Resistant Hypertension: A Systematic Review and Meta-Analysis
Meta-analysis of randomized trialsBaxdrostat

